Sling Therapeutics has closed a significant $123 million Series C financing round, directing the capital toward the pivotal late-stage clinical…
Read More
Solstice Oncology Secures $225m in Series A Financing to Advance Neoadjuvant Immuno-Oncology Therapy Porustobart
Solstice Oncology has successfully closed a landmark $225 million Series A funding round to accelerate the clinical development of its…
Read More
Encoded Therapeutics Secures $275M in Series F Financing to Advance Groundbreaking Gene Therapy for Dravet Syndrome and Expand Clinical Pipeline
Encoded Therapeutics has officially closed a massive $275 million Series F financing round, marking a critical financial milestone for the…
Read More
Citius Oncology Secures Up to $36.5 Million in Debt and Equity Financing to Fuel Lymphir Commercialization
Citius Oncology has successfully secured a significant financial infusion, totaling up to $36.5 million, through a strategic combination of debt…
Read More
Sidewinder Therapeutics Secures $137 Million in Series B Financing to Advance Bispecific Antibody-Drug Conjugate Pipeline
Sidewinder Therapeutics has announced the successful closure of a substantial $137 million Series B financing round, a significant development signaling…
Read More
